![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Boehringer finalizes Amgen acquisition
Boehringer finalizes Amgen acquisition
March 29, 2011
Boehringer has formally acquired Amgen's biopharmaceutical development and manufacturing facility in Fremont, Calif.
The state-of-the-art facility currently employs more than 300 and consists of more than 200,000 square feet of laboratory, manufacturing and process development space suitable for clinical and market supplies.
Upcoming Events
-
21Oct